Delivery Order SPE2DR25D1109-SPE2DR26FFF5F
- Not listed
- The Defense Logistics Agency awarded a $2,368.80 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Oseltamivir 6 mg/ml suspension in 60ml quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir 6 mg/ml Suspension in 60ml quantities, valued at $1,055.36. This is a firm fixed price delivery order with no set-aside designation, executed on September 19, 2025, with an ultimate completion date of September 22, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 7, 2025, for Oseltamivir 75mg in unit dose packaging (10-unit quantities) with a ceiling value of $6,249.07. This is a firm fixed price delivery order with an ultimate completion date of November 4, 2025, and represents a non-competed award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $6,974.99 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and was awarded on September 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp for Oseltamivir 75mg in unit dose packaging (10 units) valued at $6,188.16 under firm fixed-price terms. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. This competitively awarded, firm fixed-price contract carries a ceiling value of $3,699.10 and is scheduled for completion by September 25, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $1,547.04 firm fixed price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10s. The contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a competitively awarded, non-set-aside delivery order. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $2,497.20 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s, with completion targeted for September 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging on August 18, 2025, with a ceiling value of $8,385.46. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order contains no set-aside designation, allowing full and open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10 units, with a contract value of $1,042.71. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. Performance will occur at AmerisourceBergen's corporate office in...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFF5FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,801.29 to AmerisourceBergen Drug Corp for Oseltamivir 6 mg/ml suspension in 60ml quantities. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of October 24, 2025. The award was issued on October 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Oseltamivir is an antiviral medication commonly used in military and federal healthcare settings for influenza treatment and prophylaxis. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support to the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of competitively awarded contracts with DLA for diverse pharmaceutical commodities ranging from specialty medications to vaccines and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 10/23/25 |